Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /6935

Prince Pharmaceutical Co., Ltd.

6935

• TPEX: 6935 • Delayed

29.75TWD 2.6%

0.9416 USD

As of 7 June 2026, Prince Pharmaceutical Co., Ltd. has a market cap of $33.75M USD, ranking #33436 globally and #2054 in Taiwan. It ranks #3019 in the Healthcare sector, and #177 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

33436

Country Rank

2054

Sector Rank

3019

Industry Rank

177

Key Stats

Market Cap

$33.75MUSD

1.06B TWD

Enterprise Value

$42.12MUSD

1.33B TWD

Revenue (TTM)

$33.58MUSD

1.06B TWD

EBITDA (TTM)

$5.18MUSD

163.6M TWD

Net Income (TTM)

$3.06MUSD

96.32M TWD

EBITDA Margin

15%

Profit Margin

9.1%

PE Ratio

11.1

PS Ratio

1.0

PB Ratio

1.3

EV/EBITDA

7.7

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Da Li open_in_new

Employees

216

Founded

1962

Website

prince-pharm.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.6%	-3.5%	4.7%	-5.2%	-12%	-6.8%	38%	-36%	-17%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6935 王子製藥股份有限公司 ISIN: TW0006935000 Shares Out.: Shares Outstanding: 37.41M¹ TV: TradingView: TPEX: 6935 SA: Stock Analysis: TPEX: 6935 YF: Yahoo Finance: 6935.TWO GF: Google Finance: TPEX: 6935 BA: Barron's: 6935 MS: Morningstar: ROCO: 6935	29.75 TWD	TV: TradingView: TPEX: 6935 SA: Stock Analysis: TPEX: 6935 YF: Yahoo Finance: 6935.TWO GF: Google Finance: TPEX: 6935 BA: Barron's: 6935 MS: Morningstar: ROCO: 6935

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yúnlín, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Bora Pharmaceuticals Co., Ltd. TWSE: 6472	$1.68B 52.95B TWD 5K%	17.9	Taiwan
Grape King Bio Ltd. TWSE: 1707	$536.85M 16.89B TWD 1K%	14.0	Taiwan
Daiken Biomedical Co., Ltd. TWSE: 7780	$476.38M 14.99B TWD 1K%	36.5	Taiwan
TCI Co., Ltd. TPEX: 8436	$415.07M 13.06B TWD 1K%	13.7	Taiwan
Microbio Co., Ltd. TPEX: 4128	$291.68M 9.18B TWD 764%	-	Taiwan
Intelligene Inc. TPEX: 7832	$244.3M 7.69B TWD 624%	-	Taiwan

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 112K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 87K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 47K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 33K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 32K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 27K%	80.6	China

chevron_leftBack